ABSTRACT Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is spreading worldwide. Antiviral therapy is the …

Coronavirus disease 2019 (COVID-19), which is caused by a novel severe acute respiratory
syndrome coronavirus (SARS-CoV-2), has recently emerged as a global health threat. To …

Abstract Background and Objective The world is currently experiencing the Coronavirus
Disease-19 (COVID-19) pandemic. There is no approved drug for the definitive treatment of …

The anti-malarial drugs chloroquine (CQ) and hydroxychloroquine (HCQ) have been
suggested as promising agents against the new coronavirus SARS-CoV-2 that induces …

Background There is no effective therapy for COVID-19. Hydroxychloroquine (HCQ) and
chloroquine (CQ) have been used for its treatment but their safety and efficacy remain …

Since there is an urgent need for COVID-19 treatment, the pandemic disease caused by
SARS-CoV-2, the repurposing of available drugs is a quick and cheap option, with …

Drugs that are specifically efficacious against SARS-CoV-2 have yet to be established.
Chloroquine and hydroxychloroquine have garnered considerable attention for their …

Chloroquine (CQ) and its derivative, hydroxychloroquine (HCQ), have attracted wide
attention for treating coronavirus disease 2019 (COVID-19). However, conflicting outcomes …

Chloroquine (CQ) and its analogue hydroxychloroquine (HCQ) have long been used
worldwide as frontline drugs for the treatment and prophylaxis of human malaria. Since the …

What is known and Objective Non‐clinical studies suggest that chloroquine (CQ) and
hydroxychloroquine (HCQ) have antiviral activities. Early clinical reports of successful HCQ …